相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre
Matthew G. Davey et al.
BREAST JOURNAL (2021)
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis
M. G. Davey et al.
BREAST (2021)
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors- An analysis of 2765 patients from neoadjuvant clinical trials
Sonia L. Villegas et al.
EUROPEAN JOURNAL OF CANCER (2021)
Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer
M. G. Davey et al.
SURGICAL ONCOLOGY-OXFORD (2021)
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
Nicole Casasanta et al.
CLINICAL BREAST CANCER (2020)
BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database
Julia Blanter et al.
ONCOLOGY (2020)
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
Valerie E. Crolley et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients
Claudia Mazo et al.
CANCERS (2020)
Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers
Tian Tian et al.
HUMAN PATHOLOGY (2019)
St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment
Marija Balic et al.
BREAST CARE (2019)
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
Michal Vocka et al.
CANCERS (2019)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
Haixia Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer
Naama Halpern et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
Marjanka K. Schmidt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The Role of Genetic Testing in Patients With Breast Cancer A Review
Olivia M. Valencia et al.
JAMA SURGERY (2017)
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
Marjanka K. Schmidt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations
R. Lewin et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status
Payal D. Shah et al.
CANCER (2016)
Genetics of breast cancer: a topic in evolution
S. Shiovitz et al.
ANNALS OF ONCOLOGY (2015)
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Steven A. Narod et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Genetic Susceptibility to Triple-Negative Breast Cancer
Kristen N. Stevens et al.
CANCER RESEARCH (2013)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Nasim Mavaddat et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
BRCA in breast cancer: ESMO Clinical Practice Guidelines
J. Balmana et al.
ANNALS OF ONCOLOGY (2011)
Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience
Banu Arun et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Nadine Tung et al.
BREAST CANCER RESEARCH (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Histopathologic variables predict Oncotype DX™ Recurrence Score
Melina B. Flanagan et al.
MODERN PATHOLOGY (2008)
The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells
YX Ma et al.
MOLECULAR ENDOCRINOLOGY (2006)
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer:: The influence of age, grade, and histological type
WD Foulkes et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
